2022
DOI: 10.1007/s12035-022-02847-x
|View full text |Cite
|
Sign up to set email alerts
|

The Role of TDP-43 in Neurodegenerative Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(23 citation statements)
references
References 161 publications
0
23
0
Order By: Relevance
“…In normal physiological conditions, TDP-43 predominantly resides in the nucleus but can actively engage in biochemical reactions in the cytoplasm by shuttling between the cytoplasm and the nucleus. [17] TDP-43 is shown to link to the vast majority of ALS cases, accounting for approximately 97 % of them. [18] A common neuropathological hallmark is the development of cytoplasmic TDP-43 inclusion bodies, accompanied by the reduction of the typical TDP-43 presence in the nucleus.…”
Section: Amyloid Beta Peptide (Aβ)mentioning
confidence: 98%
“…In normal physiological conditions, TDP-43 predominantly resides in the nucleus but can actively engage in biochemical reactions in the cytoplasm by shuttling between the cytoplasm and the nucleus. [17] TDP-43 is shown to link to the vast majority of ALS cases, accounting for approximately 97 % of them. [18] A common neuropathological hallmark is the development of cytoplasmic TDP-43 inclusion bodies, accompanied by the reduction of the typical TDP-43 presence in the nucleus.…”
Section: Amyloid Beta Peptide (Aβ)mentioning
confidence: 98%
“…TDP-43 -a multifunctional protein with RNA/DNA binding activities and physiological localization in the cell nucleus-has been found to display functional abnormalities, including its identification as a major component of cytosolic intraneuronal and glial inclusions, in virtually all ALS patients 9,10 and a number of ALS animal models 11,12 . Thus, TDP-43 is currently thought to represent a common molecular hub in these disorders, where different pathogenic mechanisms may converge and finally result in neurotoxic cellular outcomes 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Of these proteins, TDP-43 is the most extensively studied ALS-associated RBP since its dysregulation has been directly associated with neuronal death in vitro and in vivo 14,15 and TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCIs) are observed in 97% of ALS cases 16 . TDP-43 is also the main pathological component of a group of diseases called TDP-43 proteinopathies which include frontotemporal dementia (FTD) and Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE) 17 . Because of this, there is a special interest in targeting TDP-43 as a therapeutic approach 1820 .…”
Section: Introductionmentioning
confidence: 99%